Agilent Molecular Spectroscopy Solutions For the pharmaceutical and biopharmaceutical industries

Importance of the Topic

Molecular spectroscopy methods are vital for pharmaceutical and biopharmaceutical analysis because they enable rapid, non-destructive, and high-throughput characterization of compounds and formulations. These techniques support decision making across research, development, and manufacturing by providing structural confirmation, quantitative analysis, and identification of raw materials and final products.

Objectives and Study Overview

This document presents an integrated set of analytical workflows using ultraviolet visible spectroscopy, fluorescence spectroscopy, infrared techniques, and Raman spectroscopy to address critical steps in drug discovery, development, and manufacturing. The aim is to demonstrate how a suite of instruments can streamline quality control, enhance data reliability, and reduce bottlenecks in pharmaceutical laboratories.

Methodology and Instrumentation

A comprehensive selection of molecular spectroscopy instruments is described along with their application roles. Key methods include UV-Vis absorbance for concentration and kinetics studies, fluorescence measurements for protein assays and binding interactions, FTIR and chemical imaging for material identification, and conventional and spatially offset Raman for solid dosage analysis and through-container testing.

• Ultraviolet Visible Spectrophotometers (Cary 60, Cary 3500)
• Fluorescence Spectrometer (Cary Eclipse)
• Fourier Transform Infrared Spectrometer (Cary 630)
• Laser Direct Infrared Chemical Imaging Systems
• Transmission Raman Spectroscopy (TRS 100)
• Spatially Offset Raman Spectroscopy (Vaya, RapID)

Main Results and Discussion

The Cary 60 delivers flexible UV-Vis measurements for sample volumes down to 4 µL and remote sampling via fiber-optic probes. The Cary 3500 enables simultaneous monitoring of up to eight cuvettes across multiple temperature zones, reducing analysis time from days to minutes. The TRS 100 system supports rapid, non-destructive content uniformity and identity testing of tablets in 15 minutes per batch. The Cary 630 FTIR with interchangeable modules fulfills pharmacopoeial requirements for raw material verification and polymer packaging analysis. The Cary Eclipse fluorescence spectrometer offers multiple collection modes and accessories for kinetic and structural protein studies. Portable SORS devices Vaya and RapID verify raw materials through opaque containers, enhancing warehouse throughput. The integrated software solutions support data integrity, regulatory compliance, and automated workflows.

Benefits and Practical Applications

• Improved throughput and reduced sample preparation for QA/QC.
• Simultaneous multi-sample and temperature-controlled experiments.
• Non-destructive testing of solid dosages and packaged materials.
• Compliance with global pharmacopoeial standards and electronic records regulations.
• Portable verification tools to minimize quarantine delays and maintain sample integrity.

Future Trends and Applications

Expanding automation and artificial intelligence in spectroscopy data analysis will further increase laboratory efficiency. Miniaturized and portable instruments will enable decentralized testing and real-time monitoring in production environments. Advances in hyperspectral imaging and combined modality platforms will support comprehensive process analytical technology and continuous manufacturing.

Conclusion

By integrating a broad portfolio of molecular spectroscopy instruments and software, pharmaceutical laboratories can achieve faster decisions, higher confidence in data, and streamlined compliance across drug discovery, development, and manufacturing stages.

Reference

Agilent Technologies. Analytical Workflows for Drug Discovery, Drug Development, and Drug Manufacturing. 2022.